CCXI
ChemoCentryx, Inc.
NasdaqGS
People also watch:CEMPCLRBVSTMRGLSINFI
4.69-0.01 (-0.21%)

After hours: 4.690.00 (0.00%) as of 4:55 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close4.70
Open0.00
Bid0.00 x
Ask0.00 x
52wk Range1.92 - 8.58
Day's Range4.61 - 4.75
Volume77,937
Avg Vol (3m)1,377,338
As of 4:00 PM EDT. Market closed.
  • ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
    Capital Cube2 months ago

    ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016

    Click here to see latest analysisChemoCentryx, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -15.24 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.CCXI-US‘s earnings and EBITDA are both […] (Read more...) The post ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.

  • Market Realist2 months ago

    IBB Rose 0.9% before the Long Weekend

    The iShares Nasdaq Biotechnology ETF (IBB) outperformed the Market, rising 0.9% before the long weekend.